Lung Adenocarcinoma Exhibiting Thanatosomes (Hyaline Bodies), Cytoplasmic Clearing, and Nuclear Pleomorphism, with a <i>KRAS</i> Mutation

Since epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors were introduced in 2004, various driver gene mutations have been identified in non-small cell lung cancer, particularly adenocarcinoma, where mutations are typically mutually exclusive. <i>EGFR</i> and <i>Kirs...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitsuhiro Tachibana, Yutaro Ito, Ryo Fujikawa, Kei Tsukamoto, Masahiro Uehara, Jun Kobayashi, Takuo Hayashi
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/7/894
Tags: Add Tag
No Tags, Be the first to tag this record!